Abbvie Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the second quarter 2026 to a ratio of 4.99, this is below the company average, and notable indication of worsening business environment. Average collection period, for Abbvie Inc 's accounts receivable remained unchanged at 73 days, in the Jun 30 2026 quarter.

If we take a look into Healthcare sector 374 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Jun 30 2026 from 2587 to 2661.

What is Receivable Turnover Ratio?
What is Abbvie Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

ABBV Receivables Turnover Ratio	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Receivable Change	9.39 %	0.02 %	15.29 %	11.31 %	7.79 %
Y / Y Revenue Change	10.16 %	12.43 %	10.04 %	9.1 %	6.65 %
Receivable Turnover Ratio (TTM)	4.99	4.98	4.85	4.89	4.91
ABBV's Total Ranking	# 2661	# 2587	# 2462	# 2044	# 2415
Accounts Receivable average collection period days	73	73	75	75	74
Seq. Receivable Change	10.78 %	-0.87 %	-1.41 %	1.04 %	1.28 %
Seq. Revenue Change	13.25 %	-9.72 %	5.34 %	2.29 %	15.59 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 115
Healthcare Sector	# 375
Overall Market	# 2661

Receivable Turnover Ratio Statistics
High	Average	Low
6.02	5.17	2.78
(Dec 31 2019)		(Dec. 31. 2012)

ABBV Company Profile • Back to ABBV Efficiency Comparisons • Compare ABBV Receivables Turnover Ratio to its Competitors

Financial Statements
Abbvie Inc 's Accounts Receivable	$ 13,824 Millions	Visit ABBV's Balance sheet
Abbvie Inc 's Sales TTM	$ 64,386 Millions	Visit ABBV's Income Statement
Sources of ABBV's Revenues		Visit ABBV's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
ABBV's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
ABBV's Growth Rates	ABBV's Roa	ABBV's Inventory Turnover Ratio	ABBV's Dividend Comparisons
ABBV's Profitability Ratios	ABBV's Roi	ABBV's Asset Turnover Ratio	ABBV's Dividend Growth
ABBV's Valuation Ratios	ABBV's Roe	ABBV's Financial Strength Ratios	ABBV's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Jun 30 2026	Receivable at quarter ending Jun 30 2026
Qhslab Inc	12.77	$ 3.017 Millions	$ 0.236 Millions
Nrc Health	12.72	$ 139.996 Millions	$ 11.004 Millions
Mannkind Corporation	12.39	$ 393.630 Millions	$ 31.773 Millions
Petvivo Holdings Inc	12.34	$ 1.182 Millions	$ 0.096 Millions
Siga Technologies Inc	12.32	$ 53.659 Millions	$ 4.356 Millions
Alpha Pro Tech Ltd	12.25	$ 62.204 Millions	$ 5.077 Millions
Vivos Therapeutics Inc	12.21	$ 21.135 Millions	$ 1.731 Millions
Milestone Scientific Inc	11.98	$ 8.855 Millions	$ 0.739 Millions
Teladoc Health Inc	11.88	$ 2,489.480 Millions	$ 209.556 Millions
Premier Air Charter Holdings Inc	11.72	$ 31.562 Millions	$ 2.692 Millions
Catheter Precision Inc	11.62	$ 1.915 Millions	$ 0.165 Millions
Icu Medical Inc	11.42	$ 2,159.998 Millions	$ 189.166 Millions
National Healthcare Corp	11.40	$ 1,559.020 Millions	$ 136.723 Millions
Picard Medical Inc	11.34	$ 5.983 Millions	$ 0.528 Millions
Vaso Corporation	11.31	$ 80.220 Millions	$ 7.094 Millions
Innoviva Inc	11.22	$ 420.630 Millions	$ 37.491 Millions
Lifeloc Technologies Inc	11.19	$ 9.269 Millions	$ 0.828 Millions
Veracyte Inc	11.07	$ 544.735 Millions	$ 49.194 Millions
International Stem Cell Corporation	10.91	$ 9.514 Millions	$ 0.872 Millions
Caredx Inc	10.81	$ 458.089 Millions	$ 42.359 Millions
C4 Therapeutics Inc	10.65	$ 35.039 Millions	$ 3.290 Millions
Radnet Inc	10.53	$ 2,268.932 Millions	$ 215.450 Millions
Kymera Therapeutics Inc	10.50	$ 105.000 Millions	$ 10.000 Millions
Irhythm Holdings Inc	10.42	$ 825.702 Millions	$ 79.250 Millions
Integrated Biopharma Inc	10.38	$ 42.568 Millions	$ 4.101 Millions
Viemed Healthcare Inc	10.36	$ 301.606 Millions	$ 29.102 Millions
Lensar Inc	10.33	$ 60.264 Millions	$ 5.836 Millions
Immucell Corporation	10.30	$ 29.777 Millions	$ 2.891 Millions
Addus Homecare Corp	10.25	$ 1,475.610 Millions	$ 143.923 Millions
Dariohealth Corp	10.23	$ 21.196 Millions	$ 2.072 Millions

Date modified: 2026-09-12T18:09:50+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.